Long-term Outcomes of Oxane Hd As Intraocular Tamponade in the Treatment of Complicated Retinal Detachment

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2010 Mar 23

PMID 20306070

Citations 4

Authors

Qianli Meng

Shaochong Zhang

He Cheng

Xuan Chen

Yixuan Jin

Affiliations

Soon will be listed here.

Abstract

Background: To evaluate the efficacy and safety of heavy silicone oil Oxane Hd as intraocular tamponade in the treatment of complicated retinal detachment (RD).

Methods: Forty eyes of 40 patients with complicated RD were recruited for this prospective study. Inclusion criteria were proliferative vitreoretinopathy grade > or = CP2, mainly inferior and posterior retinal breaks, or superior retinal breaks with patient's inability to posture. Oxane Hd was used as intraocular tamponade. The retinal status, the best-corrected visual acuity (BCVA) results, and any complications were observed.

Results: The mean duration of Oxane Hd endotamponade was 87.9 +/- 10.4 days, and the mean follow-up time after Oxane Hd removal was 438.1 +/- 153.7 days. The primary anatomical success rate after Oxane Hd removal was 87.5%, and with further intervention 97.5%. The BCVA significantly improved, from mean logMAR 2.12 +/- 0.60 to 1.38 +/- 0.59 (P < 0.001). The postoperative complications included temporary inflammatory reaction, moderately high intraocular pressure, heavy silicone oil emulsification, lens opacity and retinal proliferative membranes.

Conclusions: Without a requirement for postoperative prone position, heavy silicone oil Oxane Hd is effective and safe for the treatment of complicated RD with inferior and posterior breaks. Larger groups and a longer follow-up period will be included to further evaluate the efficacy with Oxane Hd in superior retinal breaks.

Citing Articles

Intraocular Pressure Rise Linked to Silicone Oil in Retinal Surgery: A Review.

Nicolai M, Lassandro N, Franceschi A, Rosati A, De Turris S, Pelliccioni P Vision (Basel). 2020; 4(3).

PMID: 32823618 PMC: 7558829. DOI: 10.3390/vision4030036.

Heavy silicone oil and intraocular inflammation.

Morescalchi F, Costagliola C, Duse S, Gambicorti E, Parolini B, Arcidiacono B Biomed Res Int. 2014; 2014:574825.

PMID: 25114909 PMC: 4119646. DOI: 10.1155/2014/574825.

Heavy silicone oil as a long-term endotamponade agent for complicated retinal detachments.

Prazeres J, Magalhaes Jr O, Lucatto L, Navarro R, Moraes N, Farah M Biomed Res Int. 2014; 2014:136031.

PMID: 24822176 PMC: 4009296. DOI: 10.1155/2014/136031.

Comprehensive analysis of inflammatory immune mediators of the intraocular fluid aspirated from the foldable capsular vitreous body filled-eyes.

Wang P, Gao Q, Lin X, Zhang S, Hu J, Liu Y PLoS One. 2012; 7(10):e46384.

PMID: 23049699 PMC: 3462176. DOI: 10.1371/journal.pone.0046384.

References

Tomlins P, Woodcock M, Spencer N, Kirkby G . Nuclear magnetic resonance analysis of emulsified silicone oil RMN-3 (Oxane HD). Br J Ophthalmol. 2007; 91(10):1379-81. PMC: 2001015. DOI: 10.1136/bjo.2006.110346. View

Wolf S, Schon V, Meier P, Wiedemann P . Silicone oil-RMN3 mixture ("heavy silicone oil") as internal tamponade for complicated retinal detachment. Retina. 2003; 23(3):335-42. DOI: 10.1097/00006982-200306000-00008. View

Romano M, Stappler T, Marticorena J, Groenewald C, Pearce I, Gibran S . Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2008; 246(11):1541-6. DOI: 10.1007/s00417-008-0894-4. View

Berker N, Batman C, Ozdamar Y, Eranil S, Aslan O, Zilelioglu O . Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment. Eur J Ophthalmol. 2007; 17(5):797-803. DOI: 10.1177/112067210701700518. View

Lappas A, Foerster A, Kirchhof B . Use of heavy silicone oil (Densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol. 2008; 87(8):866-70. DOI: 10.1111/j.1755-3768.2008.01371.x. View

Schurmans A, Van Calster J, Stalmans P . Macular hole surgery with inner limiting membrane peeling, endodrainage, and heavy silicone oil tamponade. Am J Ophthalmol. 2008; 147(3):495-500. DOI: 10.1016/j.ajo.2008.09.003. View

Holladay J . Proper method for calculating average visual acuity. J Refract Surg. 1997; 13(4):388-91. DOI: 10.3928/1081-597X-19970701-16. View

Zeana D, Becker J, Kuckelkorn R, Kirchhof B . Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol. 2000; 23(1):17-24. DOI: 10.1023/a:1006444615412. View

Quiram P, Gonzales C, Hu W, Gupta A, Yoshizumi M, Kreiger A . Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology. 2006; 113(11):2041-7. DOI: 10.1016/j.ophtha.2006.05.039. View

10.

Sandner D, Herbrig E, Engelmann K . High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol. 2007; 245(8):1097-105. DOI: 10.1007/s00417-006-0496-y. View

11.

Rizzo S, Genovesi-Ebert F, Belting C, Vento A, Cresti F . A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol. 2005; 243(11):1153-7. DOI: 10.1007/s00417-005-0015-6. View

12.

Sandner D, Engelmann K . First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2005; 244(5):609-19. DOI: 10.1007/s00417-005-0110-8. View

13.

Rizzo S, Belting C, Genovesi-Ebert F, Cresti F, Vento A, Martini R . Successful treatment of persistent macular holes using "heavy silicone oil" as intraocular tamponade. Retina. 2006; 26(8):905-8. DOI: 10.1097/01.iae.0000250006.76155.3d. View

14.

Auriol S, Pagot-Mathis V, Mahieu L, Lemoine C, Mathis A . Efficacy and safety of heavy silicone oil Densiron 68 in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol. 2008; 246(10):1383-9. DOI: 10.1007/s00417-008-0876-6. View

15.

Schiff W, Hwang J, Ober M, Olson J, Dhrami-Gavazi E, Barile G . Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol. 2007; 125(9):1161-7. DOI: 10.1001/archopht.125.9.1161. View

16.

Tseng J, Barile G, Schiff W, Akar Y, Vidne-Hay O, Chang S . Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy. Am J Ophthalmol. 2005; 140(4):628-36. DOI: 10.1016/j.ajo.2005.04.021. View

17.

Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli M . Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes. Graefes Arch Clin Exp Ophthalmol. 2009; 247(11):1471-6. DOI: 10.1007/s00417-009-1131-5. View

18.

Kirchhof B, Wong D, van Meurs J, Hilgers R, Macek M, Lois N . Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol. 2002; 133(1):95-101. DOI: 10.1016/s0002-9394(01)01295-8. View

19.

Herbrig E, Sandner D, Engelmann K . Anatomical and functional results of endotamponade with heavy silicone oil - Densiron 68 - in complicated retinal detachment. Ophthalmic Res. 2007; 39(4):198-206. DOI: 10.1159/000104681. View

20.

MACHEMER R, AABERG T, Freeman H, IRVINE A, Lean J, Michels R . An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991; 112(2):159-65. DOI: 10.1016/s0002-9394(14)76695-4. View